Original ContributionPoor lysosomal membrane integrity in proximal tubule cells of haptoglobin 2-2 genotype mice with diabetes mellitus
Highlights
► Renal proximal tubule cell (PTC) lysosomes of Hp 2-2 DM mice have iron deposits. ► Renal PTC lysosomal membranes of Hp 2-2 DM mice are oxidized. ► PTC lysosomal membrane integrity of Hp 2-2 DM mice is compromised. ► Vitamin E stabilizes PTC lysosomal membrane integrity in Hp 2-2 DM mice. ► Iron-induced injury may explain increased nephropathy in Hp 2-2 DM humans.
Section snippets
Animal studies
All procedures were approved by the Animal Care Committee of the Technion (protocol number IL-112-11-11). All mice were of a C57B1/6 genetic background. The Hp 2 allele is present only in humans. All other species have only an Hp 1 allele, which is highly homologous with the human Hp 1 allele. Thus, wild-type mice carry the Hp 1 allele (referred herein as Hp 1-1 mice). The construction of the murine Hp 2 allele and the targeting of its insertion by homologous recombination to the murine Hp
Increased iron-rich deposits in lysosomes of proximal tubule cells in Hp 2-2 DM mice
We sought to assess the intracellular localization of iron within the proximal tubules using TEM. TEM demonstrated a marked accumulation of electron-dense deposits in the lysosomes of proximal tubule cells (Fig. 1A). EDX and EELS were used to perform elemental analysis of these deposits and demonstrated that these deposits were iron rich (Fig. 1B). Lysosomes containing these iron deposits were more frequent in the proximal tubule of Hp 2-2 (65±4% of all lysosomes) compared with Hp 1-1 DM mice
Discussion
In this study we have demonstrated that increased lysosomal redox-active iron results in lysosomal membrane injury in renal cells of Hp 2-2 DM mice. These data therefore provide a novel pathophysiological mechanism explaining why the progression to end-stage renal disease is increased in DM individuals with the Hp 2-2 DM genotype. Moreover, the interaction between the vitamin E and the Hp genotype on lysosomal injury suggests that a pharmacogenomic paradigm of selective administration of
Acknowledgments
This work was supported by a grant from the Israel Society Foundation (ISF) to F.M. Nakhoul and in part from Aboutboul Family in memory of Daniel Aboutboul and by grants from NIH (R01DK085226) and the ISF to A.P.L. This work was also generously supported by a grant from the Slava Smolakovski Fund to the Rambam-Atidim Academic Excellence Program. The electron-microscopic analyses were supported by the Dan David Foundation to T.C.I. and I.M. M.L. thanks Gerd Fulda for operating the microscope.
References (35)
- et al.
Insights to the genetics of diabetic nephropathy through a genome-wide association study of the GoKinD collection
Semin. Nephrol.
(2010) - et al.
The genetics of vascular complications in diabetes mellitus
Cardiol. Clin.
(2010) - et al.
Tubular changes in early diabetic nephropathy
Adv. Chronic Kidney Dis.
(2005) Ferritin and hemosiderin in pathological tissues
Electron Microsc. Rev
(1992)- et al.
A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent
J. Lipid Res.
(1989) - et al.
Simultaneous determination of tissue tocopherols, tocotrienols, ubiquinols, and ubiquinones
J. Lipid Res.
(1996) - et al.
Molecular bases of cellular iron toxicity
Free Radic. Biol. Med.
(2002) - et al.
Structure-function analysis of the antioxidant properties of haptoglobin
Blood
(2001) - et al.
Haptoglobin genotype is a major determinant of the amount of iron in the human atherosclerotic plaque
J. Am. Coll. Cardiol.
(2008) - et al.
Prevention of oxidant-induced cell death by lysosomotropic iron chelators
Free Radic. Biol. Med.
(2003)
Global and societal implications of the diabetes epidemic
Nature
Genetics of diabetic nephropathy: are there clues to the understanding of common kidney diseases?
Nephron Clin. Pract.
A review of oxidative stress related genes and new antioxidant therapy in diabetic nephropathy
Cardiovasc. Hematol. Agents Med. Chem
A hemochromatosis-causing mutation C282Y is a risk factor for proliferative diabetic retinopathy in Caucasians with type 2 diabetes
J. Hum. Genet.
Petrovic, D. GSTT1 null genotype is a risk factor for diabetic retinopathy in Caucasians with type 2 diabetes, whereas GSTM1 null genotype might confer protection against retinopathy
Dis. Markers
Haemochromatosis-causing mutations C282Y and H63D are not risk factors for coronary artery disease in Caucasians with type 2 diabetes
Fol. Biol. (Praha)
Biological and clinical significance of haptoglobin polymorphism in humans
Clin. Chem.
Cited by (17)
Chronic interstitial nephritis in agricultural communities (CINAC) and lysosomal tubulopathy: Is there a place for anti-oxidants?
2021, Medical HypothesesCitation Excerpt :Hydrogen peroxide (or TNF and lipopolysaccharides that induce its production) destabilizes lysosomal membranes leading to the release of hydrolytic enzymes to the cytoplasm and eventually cell death. Animal studies have shown that Vitamin E inhibits lysosomal membrane lipid peroxidation and loss of lysosomal membrane integrity in proximal tubules of transgenic mice who accumulated excess iron deposits [20]. High dose vitamin E reduces tubulointerstitial fibrosis and autophagic stress in the diabetic rat model.
Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy
2021, Free Radical Biology and MedicineCitation Excerpt :Iron functions as a cofactor for vital iron-containing enzymes, involving ATP production, DNA and heme synthesis and many other physiological activities [3]. However, the deposition of iron in the cells causes tissue dysfunction, which detected in the proximal tubular lysosomes of DN patients and diabetic mice [4–7]. The research showed that a low-iron diet or iron chelators could delay the progress of DN in diabetic rats [8].
The Haptoglobin genotype predicts cardio-renal mortality in type 1 diabetes
2016, Journal of Diabetes and its ComplicationsCitation Excerpt :Prospective data on the HP genotype–kidney function association are also limited to results from the EDC and DCCT/EDIC studies in type 1 diabetes (Costacou et al., 2009; Orchard et al., 2013) while similar data from prospective studies in type 2 diabetes are completely lacking in humans. Nevertheless, investigators have previously reported significantly increased glomerular and proximal tubular hypertrophy in mice with diabetes and the HP 2-2 genotype (Asleh et al., 2012; Nakhoul et al., 2009). Interestingly, administration of vitamin E was shown to yield benefits in terms of kidney disease in diabetic mice carrying the HP 2-2 genotype, slowing disease progression (Nakhoul et al., 2009) and reducing the oxidation of the lysosomes (Asleh et al., 2012).
Is the Hp 2-2 diabetic mouse model a good model to study diabetic nephropathy?
2013, Diabetes Research and Clinical PracticeCitation Excerpt :In order to determine if the increased iron-rich deposits in Hp 2-2 DM mice had the potential to produce reactive oxygen species, we assessed redox-active chelatable iron in lysosomes of Hp 1-1 and 2-2 DM mice. We found a 2-fold increase in the amount of redox active iron in the lysosomes of Hp 2-2 DM mice (0.56 ± 0.07 μM) as compared with those from Hp 1-1 DM mice 0.23 ± 0.14 μM P = 0.036) [17]. Diabetic retinopathy and blindness remains important complications of diabetes.
Development of a sensitive and reliable ELISA kit of urinary haptoglobin to predict progress of diabetic kidney disease
2021, Diabetes/Metabolism Research and ReviewsResearch progress on the relationship between haptoglobin and diabetic kidney disease
2021, International Journal of Ophthalmology
- 1
Both authors contributed equally to this manuscript.